In this study, we aimed to evaluate the roles of PD-L2 in lung cancer pathogenesis, and found that this molecule promoted NSCLC progression in vivo with recruitment of regulatory T cells (Tregs). This evidence concerns the gene PDCD1LG2 and lung carcinoma.